The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for...
Efforts to advance the first-ever vaccine against Middle East Respiratory Syndrome (MERS) are progressing, with a new in...
The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open fo...
Japan's Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.7 b...
US-based PharmaJet, a company that strives to improve the performance and outcomes of injectables with its enabling...
South Korea-based SK bioscience, a global innovative vaccine and biotech company committed to promoting human health fro...
South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...
The Asia Pacific Immunization Coalition (APIC) and the Asia Dengue Voice & Action (ADVA), with the Centre for Behavi...
South Korea-based SK bioscience, and global healthcare leader Sanofi, are strengthening their partnership to jointly tar...
Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (H...
Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...
Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...
In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...
South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...
Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...
A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...
